Pluri (PLUR) Change in Acquisitions & Divestments (2010 - 2023)
Pluri (PLUR) posted quarterly Change in Acquisitions & Divestments of $5.9 million for Q3 2023, down 8.68% year-over-year from $6.5 million in Q3 2022, and up 33.57% quarter-over-quarter from $4.4 million in Q2 2023.
Pluri (PLUR) Change in Acquisitions & Divestments (2010 - 2023) Analysis & Trends
Pluri (PLUR) has reported Change in Acquisitions & Divestments for 14 consecutive years, with $5.9 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Change in Acquisitions & Divestments fell 8.68% year-over-year to $5.9 million; the TTM figure through Sep 2023 stood at $9.4 million (down 69.3% YoY), while the FY2023 annual figure was $10.0 million, down 17.43% from the prior year.
- Change in Acquisitions & Divestments advanced to $5.9 million in Q3 2023 per PLUR's latest filing, from $4.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $16.3 million in Q2 2022 and bottomed at -$29.4 million in Q2 2020.
- Historically, Change in Acquisitions & Divestments has averaged $825882.4 across 5 years, with a median of $2.1 million in 2021.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments tumbled 421.9% — and 2022, when it surged 676.37%.
- Pluri's Change in Acquisitions & Divestments stood at $6.0 million in 2019, then slumped by 121.88% to -$1.3 million in 2020, then surged by 600.0% to $6.5 million in 2021, then sank by 88.74% to $737000.0 in 2022, then soared by 701.22% to $5.9 million in 2023.
- Business Quant data shows PLUR's Change in Acquisitions & Divestments at $5.9 million in Q3 2023, $4.4 million in Q2 2023, and -$1.7 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 5.91 Mn |
| Sep 30, 2023 | 5.91 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Mar 31, 2023 | -1.66 Mn |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | 737,000.00 |
| Dec 31, 2022 | 737,000.00 |
| Sep 30, 2022 | 6.47 Mn |
| Sep 30, 2022 | 6.47 Mn |
| Jun 30, 2022 | 16.30 Mn |
| Jun 30, 2022 | 16.30 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | -12.08 Mn |
| Sep 30, 2021 | -12.08 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |